Peritoneal cavity is a route for gut-derived microbial signals to promote autoimmunity in non-obese diabetic mice

Scandinavian Journal of Immunology

Volumn 81, Issue 2, 2015, Pages 102-109

  Emani, R ^a   Alam, C ^b   Pekkala, S ^c   Zafar, S ^a   Emani, M R ^d   Hanninen A ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c UNIVERSITY OF JYVÄSKYLÄ   (Finland)

^d TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; CD69 ANTIGEN; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK3 PROTEIN, MOUSE; LECTIN; LEUKOCYTE ANTIGEN; LIPOPOLYSACCHARIDE; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE; LYMPH NODE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS; PERITONEAL CAVITY; PERITONEUM LAVAGE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; T LYMPHOCYTE; WEANING; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; AUTOIMMUNITY; BLOTTING, WESTERN; CELLS, CULTURED; FLOW CYTOMETRY; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTESTINES; LECTINS, C-TYPE; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; MICROBIOTA; PERITONEAL CAVITY; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; WEANING;

EID: 84921405954     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12253     Document Type: Article

References (29)

1. Denis MC, Mahmood U, Benoist C, Mathis D, Weissleder R. Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc Natl Acad Sci U S A 2004;101:12634-9.
2. Lefebvre DE, Powell KL, Strom A, Scott FW. Dietary proteins as environmental modifiers of type 1 diabetes mellitus. Annu Rev Nutr 2006;26:175-202.
3. Kriegel MA, Sefik E, Hill JA, Wu HJ, Benoist C, Mathis D. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U S A 2011;108:11548-53.
4. Roep BO. The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure. Diabetologia 2003;46:305-21.
5. Goudy KS, Tisch R. Immunotherapy for the prevention and treatment of type 1 diabetes. Int Rev Immunol 2005;24:307-26.
6. Skog O, Korsgren S, Melhus A, Korsgren O. Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease. Curr Opin Endocrinol Diabetes Obes 2013;20:118-23.
7. Silveira PA, Grey ST. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes. Trends Endocrinol Metab 2006;17:128-35.
8. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009;27:451-83.
9. Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc Biol 2006;79:285-93.
10. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35.
11. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010;32:593-604.
12. Kreider T, Anthony RM, Urban JF Jr, Gause WC. Alternatively activated macrophages in helminth infections. Curr Opin Immunol 2007;19:448-53.
13. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117:175-84.
14. O'Brien BA, Huang YQ, Trudeau J et al. In vivo phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes 2002;51:A287-8.
15. O'Brien BA, Geng X, Orteu CH et al. A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun 2006;26:104-15.
16. Rosati O, Martin MU. Identification and characterization of murine IRAK-2. Biochem Biophys Res Commun 2002;297:52-8.
17. Wesche H, Gao X, Li X, Kirschning CJ, Stark GR, Cao Z. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem 1999;274:19403-10.
18. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002;110:191-202.
19. Alam C, Valkonen S, Palagani V, Jalava J, Eerola E, Hanninen A. Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change. Diabetes 2010;59:2237-46.
20. Emani R, Asghar MN, Toivonen R et al. Casein hydrolysate diet controls intestinal T cell activation, free radical production and microbial colonisation in NOD mice. Diabetologia 2013;56:1781-91.
21. Maurano F, Mazzarella G, Luongo D et al. Small intestinal enteropathy in non-obese diabetic mice fed a diet containing wheat. Diabetologia 2005;48:931-7.
22. Newton S, Ding Y, Chung CS, Chen Y, Lomas-Neira JL, Ayala A. Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response. Surg Infect (Larchmt) 2004;5:375-83.
23. Li L, Cousart S, Hu J, McCall CE. Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J Biol Chem 2000;275:23340-5.
24. Wysocka M, Robertson S, Riemann H et al. IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness. J Immunol 2001;166:7504-13.
25. Cole TS, Zhang M, Standiford TJ et al. IRAK-M modulates expression of IL-10 and cell surface markers CD80 and MHC II after bacterial re-stimulation of tolerized dendritic cells. Immunol Lett 2012;144:49-59.
26. Da Gama LM, Ribeiro-Gomes FL, Guimaraes U Jr, Arnholdt AC. Reduction in adhesiveness to extracellular matrix components, modulation of adhesion molecules and in vivo migration of murine macrophages infected with Toxoplasma gondii. Microbes Infect 2004;6:1287-96.
27. Geutskens SB, Nikolic T, Dardenne M, Leenen PJ, Savino W. Defective up-regulation of CD49d in final maturation of NOD mouse macrophages. Eur J Immunol 2004;34:3465-76.
28. Turley SJ, Lee JW, Dutton-Swain N, Mathis D, Benoist C. Endocrine self and gut non-self intersect in the pancreatic lymph nodes. Proc Natl Acad Sci U S A 2005;102:17729-33.
29. Alam C, Valkonen S, Ohls S, Tornqvist K, Hanninen A. Enhanced trafficking to the pancreatic lymph nodes and auto-antigen presentation capacity distinguishes peritoneal B lymphocytes in non-obese diabetic mice. Diabetologia 2010;53:346-55.